Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan

Methotrexate (MTX), the primary treatment for the articular-type juvenile idiopathic arthritis (JIA), is effective and brings about radiological improvement. Patient compliance is good, and it is recognized that its known side effects, namely, disruption of liver function and induction of pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Masaaki, Naruto, Takuya, Imagawa, Tomoyuki, Murata, Takuji, Takei, Syuji, Tomiita, Minako, Itoh, Yasuhiko, Fujikawa, Satoshi, Yokota, Shumpei
Formato: Texto
Lenguaje:English
Publicado: Springer Japan 2008
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638602/
https://www.ncbi.nlm.nih.gov/pubmed/18815725
http://dx.doi.org/10.1007/s10165-008-0123-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2638602/
https://www.ncbi.nlm.nih.gov/pubmed/18815725
http://dx.doi.org/10.1007/s10165-008-0123-3

Ejemplares similares